Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > February 11th

<< Previous

Bullboard Posts

Next >>

Comment by Alba1314on Feb 08, 2019 11:51am

106 Views

Post# 29338148

RE:RE:RE:February 11th

I have about 420K shares in total across three accounts. Averaged about $.09

Betting on a JV. My big fear was massive dillution but with the pp, I think that kills that idea. I think the pp keeps the lights on and a JV will pay for the trials. I'd havce to check but I thinbk they 2-3 planned for this year?

Can't give a sell range. totally dependant on market reactioni to any news.

<< Previous

Bullboard Posts

Next >>

StockTalk | Cannabis Report: New CEO, new dispensaries, new strains